SciLifeLab
SciLifeLab is a Swedish national research infrastructure founded in 2010, providing academic, healthcare, and industry researchers with access to nine advanced molecular bioscience platforms—including genomics, proteomics, spatial omics, and drug discovery—and supporting staff across most Swedish universities.
- Company typePrivate
- Founded2010
- HeadquartersSolna, Sweden
- Headcount501–1,000
- GTM typeB2B
- OfferingServices
What SciLifeLab does
SciLifeLab (Science for Life Laboratory) is a Swedish national research infrastructure founded in 2010 as a joint initiative of Karolinska Institutet, KTH Royal Institute of Technology, Stockholm University, and Uppsala University, now represented at most Swedish universities. The organization provides researchers in biomedicine, ecology, and evolution with access to advanced technologies and dedicated staff-scientist support across nine core platforms: Genomics, Proteomics, Metabolomics and Exposomics, Spatial Omics, Cellular and Molecular Imaging, Structural Biology, Chemical Biology and Genome Engineering, Drug Discovery, and Bioinformatics. Three strategic areas—Planetary Biology, Translation to Healthcare (Precision Medicine), and Pandemic Laboratory Preparedness—organize cross-platform programs; the pandemic preparedness line was government-commissioned at 130 MSEK for 2021–2024.
The business model is government-commissioned infrastructure rather than commercial SaaS or product sales. SciLifeLab is funded through Swedish government allocations, founding-university support, and program-specific grants (e.g., 12 MSEK for the SPRINTR precision-medicine cancer platform via the National Board of Health and Welfare). Pricing is not publicly disclosed; users access platforms via their host universities, healthcare institutions (notably Karolinska University Hospital), and approved research collaborations. Notable technical outputs include the SIXP spatial interactomics platform (with Navinci, Uppsala University, CBCS, and Pixl Bio), the ProBio Prostatacancer Assay (cfDNA sequencing for BRCA1/BRCA2 with the Jumble bioinformatic algorithm, now in routine clinical use across the Nordics), and the Clinical Genomics facility (more than 130,000 samples analyzed and 22,000+ whole genomes sequenced during 2021–2024). Distribution is concentrated in Sweden across Stockholm, Uppsala, Solna, Lund, Umeå, Linköping, and Gothenburg, with early Nordic-region extension through the ProBio Assay.
SciLifeLab firmographics
Firmographics- Name
- SciLifeLab
- Legal name
- Science for Life Laboratory (SciLifeLab)
- Website
- https://scilifelab.se
- Company type
- Private
- Founded year
- 2010
- Operating status
- Operating
- Headcount range
- 501–1,000 employees
- Short description
- SciLifeLab is a Swedish national research infrastructure founded in 2010, providing academic, healthcare, and industry researchers with access to nine advanced molecular bioscience platforms—including genomics, proteomics, spatial omics, and drug discovery—and supporting staff across most Swedish universities.
- Ownership category
- akta.pro rank
SciLifeLab industry classification
Industry- Product category
- Life Science Research Infrastructure
- NAICS
- Research and Development in Biotechnology (except Nanobiotechnology) (541714)
- akta.pro primary industry
- Biomedical Sciences & Medical Research Institutes (University-Based) (EDAHAGAI)
- akta.pro secondary industries
- Synthetic Biology & Genetic Circuit Design Platforms (pathway engineering, chassis development) (HLAAAIAD), Biology & Life Science Enrichment (Biotech, Genetics, Anatomy) (EDAMABAF)
Keywords
Where SciLifeLab is headquartered
LocationHeadquarters
- HQ city
- Solna
- HQ country
- Sweden
- HQ region
- Europe
Offices6 records
Markets served
SciLifeLab business model
Business model- GTM type
- B2B
- Offering type
- Services
Revenue model
- Research Infrastructure Services: SciLifeLab provides access to advanced research technologies and expertise to researchers in academia, healthcare, and industry. As a government-commissioned national infrastructure, funding comes from government sources, with services provided to users across Sweden's research ecosystem.
Go-to-market motion1 record
Distribution channels3 records
Marketing channels5 records
SciLifeLab product offering
Product offeringCore offering
No substantive information about SciLifeLab's core offerings was provided in the source input.
Product overview
SciLifeLab (Science for Life Laboratory) is a state-of-the-art national infrastructure for life science that operates as a platform-plus-core-facilities architecture. The core consists of nine technology platforms: Genomics, Proteomics, Metabolomics and Exposomics, Spatial Omics, Cellular and Molecular Imaging, Structural Biology, Chemical Biology and Genome Engineering, Drug Discovery, and Bioinformatics. These are complemented by strategic capabilities including Planetary Biology, Translation to Healthcare (Precision Medicine), and Pandemic Laboratory Preparedness. The organization offers the Training Portal for educational resources, runs the PULSE postdoctoral training program, and manages flagship research initiatives. Key products include the SIXP Platform for high-throughput spatial interactomics and the ProBio Prostatacancer Assay for metastatic prostate cancer diagnostics. The Clinical Genomics facility provides advanced DNA/RNA sequencing services, and the organization administers the Science & SciLifeLab Prize for Young Scientists. Collaboration across disciplines and sectors involves healthcare, academia, industry, and international communities to enable life science research.
Differentiator
Problem solved
Functional benefit
Brands
- Science & SciLifeLab Prize for Young Scientists: A global prize established in 2013, awarded in partnership with Science magazine/AAAS to recognize scientists at an early stage of their careers.
Quantifiable outcome
- 40% molecular diagnosis rate for rare inherited diseases
- +2 more outcomes
Companies that use SciLifeLab
Customer profileNamed customers3 records
Segments3 records
SciLifeLab technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration1 record
AI capability4 records
Feature3 records
SciLifeLab partnerships and signals
Strategic signalPartnerships
13 partnerships are on record, tiered core, strategic and minor.
- Karolinska InstitutetcoreFounding partner of SciLifeLab along with KTH Royal Institute of Technology, Stockholm University, and Uppsala University. Founded in 2010 as a joint effort. Karolinska Institutet hosts Clinical Genomics Stockholm facility and key researchers including Johan Lindberg.
- KTH Royal Institute of TechnologycoreFounding partner of SciLifeLab. Contributes research expertise and hosts infrastructure facilities as part of the national research collaboration.
- Stockholm UniversitycoreFounding partner of SciLifeLab. Contributes academic research capabilities and expertise to the national infrastructure collaboration.
- Uppsala UniversitycoreFounding partner of SciLifeLab. Hosts SciLifeLab Uppsala facilities including Navet BMC. Collaborates on research projects including the Navinci spatial interactomics collaboration.
- NavincistrategicCross-institutional collaboration to develop the SIXP platform for high-throughput spatial interactomics. Project combines Navinci's multiplex in situ proximity ligation assay technology with cell painting and AI-driven image analysis for drug discovery.
- Chemical Biology Consortium Sweden (CBCS)strategicCBCS infrastructure at SciLifeLab will implement the established SIXP technology for national access to spatial interactomics capabilities for researchers across Sweden.
- Pixl BiominorCollaborator in cross-institutional project for high-throughput spatial interactomics platform development.
- Karolinska University HospitalcoreClinical implementation partner for ProBio Prostatacancer Assay developed by SciLifeLab and Karolinska Institutet researchers. Now offers routine diagnostic testing for metastatic prostate cancer patients.
- Region VästerbottenstrategicLead organization for SPRINTR study receiving 12 million SEK government funding to develop national research platform in precision medicine for cancer.
- Umeå UniversitystrategicPartner in SPRINTR study leading development of national research platform in precision medicine for cancer, alongside Region Västerbotten.
- Genomic Medicine SwedenstrategicReceiving government funding as part of precision health initiatives under same government decision as SPRINTR study.
- Biobank SwedenstrategicReceiving government funding as part of precision health initiatives under same government decision as SPRINTR study.
- National Board of Health and Welfare (Socialstyrelsen)coreGovernment body providing 12 million SEK funding for SPRINTR study and precision medicine platform development, with additional funding to Genomic Medicine Sweden and Biobank Sweden.
Scale indicators10 records
Recent moves7 records
Expansion highlights6 records
SciLifeLab competitors and assessment
Company assessmentDirect peers
- European Molecular Biology Laboratory (EMBL): EMBL is Europe's flagship intergovernmental life-sciences research infrastructure offering advanced technology platforms (genomics, structural biology, imaging, bioinformatics) to member-state researchers. Highly comparable to SciLifeLab in mission, governance, and core facility portfolio, though operating at a pan-European rather than national scale.
- Broad Institute of MIT and Harvard: Broad is a leading US genomics and chemical biology research institute operating shared technology platforms (genomics, proteomics, imaging, chemistry) serving academic and clinical researchers. Comparable platform-plus-research model to SciLifeLab, at larger scale and with deeper commercial spin-out activity.
- The Francis Crick Institute: The Crick is a UK biomedical discovery institute with interdisciplinary research groups and shared core technology facilities. Comparable to SciLifeLab's model of clustering infrastructure around a multi-institutional research community focused on molecular biosciences.
- Nordic EMBL Partnership for Molecular Medicine: The Nordic EMBL Partnership is a network of Nordic molecular medicine research nodes (including nodes in Sweden, Denmark, Norway, Finland) with overlapping missions to SciLifeLab. Directly comparable as a regional, multi-node, publicly funded life science infrastructure operating in the same geographic ecosystem.
- Genomics England: Genomics England is a UK government-owned company running the 100,000 Genomes Project and providing clinical whole-genome sequencing infrastructure for the NHS. Directly comparable to SciLifeLab's Clinical Genomics and rare disease sequencing initiatives from a translational genomics perspective.
- Wellcome Sanger Institute: Sanger is a UK-based genomics and bioinformatics research institute operating large-scale DNA sequencing, cancer genomics, and infectious disease surveillance capabilities. Directly comparable to SciLifeLab's Clinical Genomics Stockholm in scale, mission, and translational genomics focus.
Broad incumbents
- Illumina: Illumina is the dominant commercial DNA sequencing platform provider and runs its own accelerator and genomics network programs. Indirect peer in that SciLifeLab's Clinical Genomics operations depend on Illumina technology while also competing for translational genomics mindshare.
- 10x Genomics: 10x Genomics is a US-based commercial provider of single-cell, spatial omics, and genomics platforms used widely by research infrastructure operators. Overlaps with SciLifeLab's Genomics, Spatial Omics, and Cellular Imaging platforms from a technology-provider standpoint, though as a vendor rather than a peer institute.
- Max Planck Institutes (Biomedical Section): The Max Planck Society operates a broad network of biomedical research institutes across Germany with shared infrastructure and core facilities. Overlaps with SciLifeLab in providing large-scale, publicly funded life science infrastructure, though distributed across many specialized institutes rather than centralized.
Regional players
- Babraham Institute: Babraham is a UK life sciences research institute focused on epigenetics, signaling, and immunology with shared research infrastructure. Smaller-scale peer in the same European ecosystem, comparable in its mix of academic research groups and core facility access.
Market position
Strengths5 records
Weaknesses4 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
SciLifeLab social profiles
Digital presenceSciLifeLab financial estimates
Financial estimateRevenue estimate
Valuation estimate
SciLifeLab leadership team
Management profileNumber of profiles
SciLifeLab funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
SciLifeLab M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about SciLifeLab
What does SciLifeLab do?
No substantive information about SciLifeLab's core offerings was provided in the source input.
Is SciLifeLab a public or private company?
SciLifeLab is a private company. It is classified as unknown and is currently operating.
When was SciLifeLab founded?
SciLifeLab was founded in 2010. It employs 501 to 1,000 people.
Where is SciLifeLab based?
SciLifeLab is headquartered in Solna, Sweden, in the Europe region.
How does SciLifeLab make money?
One revenue line is on record: research Infrastructure Services.
Who are SciLifeLab's main competitors?
Direct peers on record are European Molecular Biology Laboratory (EMBL), Broad Institute of MIT and Harvard, The Francis Crick Institute, Nordic EMBL Partnership for Molecular Medicine, Genomics England and Wellcome Sanger Institute. Broad incumbents are Illumina, 10x Genomics and Max Planck Institutes (Biomedical Section). Babraham Institute is listed as a regional player.
Does SciLifeLab have an API?
No public API is recorded for SciLifeLab.
What industry is SciLifeLab in?
SciLifeLab's product category is Life Science Research Infrastructure. Its primary akta.pro industry code is EDAHAGAI, Biomedical Sciences & Medical Research Institutes (University-Based), with a secondary code of HLAAAIAD, Synthetic Biology & Genetic Circuit Design Platforms (pathway engineering, chassis development). Its NAICS code is 541714.